Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Pieris Pharmaceuticals, Inc. (PIRS) had Receiveable Turnover of 7.09 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$42.81M |
|
$-24.54M |
|
-- |
|
$42.81M |
|
$72.57M |
|
$-29.76M |
|
$5.21M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-29.76M |
|
$-27.85M |
|
90.06M |
|
90.06M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$38.68M |
|
-- |
|
-- |
|
$38.68M |
|
$11.92M |
|
-- |
|
-- |
|
$11.92M |
|
$26.76M |
|
$26.76M |
|
$26.76M |
|
98.94M |
|
| Cash Flow Statement Financials | |
$-53.82M |
|
$12.00M |
|
$19.80M |
|
$38.63M |
|
$17.40M |
|
$-21.24M |
|
$3.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-69.51% |
|
-69.51% |
|
-65.06% |
|
-57.33% |
|
-57.33% |
|
$-53.99M |
|
-- |
|
-- |
|
-- |
|
1.11 |
|
-- |
|
|
Receiveable Turnover |
7.09 |
51.49 |
|
-91.72% |
|
-91.72% |
|
-63.45% |
|
-91.72% |
|
$0.27 |
|
$-0.60 |
|
$-0.60 |
|